TELADOC HEALTH INC (TDOC)
US87918A1051 - Common Stock
Taking everything into account, TDOC scores 4 out of 10 in our fundamental rating. TDOC was compared to 40 industry peers in the Health Care Technology industry. While TDOC seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, TDOC is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
TDOC had negative earnings in the past year.
In the past year TDOC had a positive cash flow from operations.
TDOC had negative earnings in each of the past 5 years.
Of the past 5 years TDOC 4 years had a positive operating cash flow.
1.2 Ratios
TDOC has a Return On Assets of -5.39%. This is in the better half of the industry: TDOC outperforms 74.36% of its industry peers.
TDOC has a better Return On Equity (-10.18%) than 76.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.39% | ||
| ROE | -10.18% | ||
| ROIC | N/A |
ROA(3y)-107.27%
ROA(5y)-66.14%
ROE(3y)-201.33%
ROE(5y)-123.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 70.82%, TDOC is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of TDOC has remained more or less at the same level.
TDOC does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.82% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.46%
2. Health
2.1 Basic Checks
TDOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for TDOC has been increased compared to 1 year ago.
TDOC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, TDOC has an improved debt to assets ratio.
2.2 Solvency
TDOC has an Altman-Z score of -3.58. This is a bad value and indicates that TDOC is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.58, TDOC is not doing good in the industry: 64.10% of the companies in the same industry are doing better.
The Debt to FCF ratio of TDOC is 7.72, which is on the high side as it means it would take TDOC, 7.72 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.72, TDOC is in the better half of the industry, outperforming 74.36% of the companies in the same industry.
TDOC has a Debt/Equity ratio of 0.67. This is a neutral value indicating TDOC is somewhat dependend on debt financing.
TDOC's Debt to Equity ratio of 0.67 is on the low side compared to the rest of the industry. TDOC is outperformed by 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 7.72 | ||
| Altman-Z | -3.58 |
ROIC/WACCN/A
WACC8.46%
2.3 Liquidity
TDOC has a Current Ratio of 3.82. This indicates that TDOC is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.82, TDOC is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
TDOC has a Quick Ratio of 3.74. This indicates that TDOC is financially healthy and has no problem in meeting its short term obligations.
TDOC has a Quick ratio of 3.74. This is in the better half of the industry: TDOC outperforms 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.82 | ||
| Quick Ratio | 3.74 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 96.76% over the past year.
TDOC shows a small growth in Revenue. In the last year, the Revenue has grown by 6.01%.
TDOC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 44.17% yearly.
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-16.67%
Revenue 1Y (TTM)6.01%
Revenue growth 3Y33.49%
Revenue growth 5Y44.17%
Revenue growth Q2Q2.69%
3.2 Future
Based on estimates for the next years, TDOC will show a very strong growth in Earnings Per Share. The EPS will grow by 20.15% on average per year.
Based on estimates for the next years, TDOC will show a small growth in Revenue. The Revenue will grow by 6.66% on average per year.
EPS Next Y21.39%
EPS Next 2Y21%
EPS Next 3Y19.7%
EPS Next 5Y20.15%
Revenue Next Year2.06%
Revenue Next 2Y2.85%
Revenue Next 3Y3.07%
Revenue Next 5Y6.66%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TDOC. In the last year negative earnings were reported.
Also next year TDOC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TDOC indicates a rather cheap valuation: TDOC is cheaper than 97.44% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TDOC indicates a rather cheap valuation: TDOC is cheaper than 94.87% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.82 | ||
| EV/EBITDA | 5.55 |
4.3 Compensation for Growth
A more expensive valuation may be justified as TDOC's earnings are expected to grow with 19.70% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21%
EPS Next 3Y19.7%
5. Dividend
5.1 Amount
TDOC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TELADOC HEALTH INC
NYSE:TDOC (4/30/2024, 7:26:57 PM)
Premarket: 12.7 -0.05 (-0.39%)12.75
-0.64 (-4.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.16B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -5.39% | ||
| ROE | -10.18% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.82% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.61
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.82 | ||
| Quick Ratio | 3.74 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)96.76%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y21.39%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)6.01%
Revenue growth 3Y33.49%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y